I agree that this site is using cookies. You can find further informations here.
X
Bernabeu, I.
333  results:
Search for persons X
?
1

Pituitary surgery in elderly patients: a safe and effective..:

Villar-Taibo, R. ; Díaz-Ortega, C. ; Sifontes-Dubon, M....
Endocrine.  72 (2021)  3 - p. 814-822 , 2021
Link: https://doi.org/10.1007/..
 
?
2

Erratum to: Safety of long-term treatment with Pegvisomant:..:

Spanish ACROSTUDY Group ; Bernabeu, I. ; Pico, A....
Pituitary.  19 (2016)  4 - p. 460-460 , 2016
Link: https://doi.org/10.1007/..
 
?
3

Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through a..:

Garcia-Rendueles, A R ; Rodrigues, J S ; Garcia-Rendueles, M E R...
Oncogene.  36 (2016)  5 - p. 652-666 , 2016
Link: https://doi.org/10.1038/..
 
?
4

Safety of long-term treatment with Pegvisomant: analysis of..:

Spanish ACROSTUDY Group ; Bernabeu, I. ; Pico, A....
Pituitary.  19 (2015)  2 - p. 127-137 , 2015
Link: https://doi.org/10.1007/..
 
?
5

Update on prognostic factors in acromegaly: Is a risk score..:

Fernandez-Rodriguez, E. ; Casanueva, F. F. ; Bernabeu, I.
Pituitary.  18 (2014)  3 - p. 431-440 , 2014
Link: https://doi.org/10.1007/..
 
?
6

Influence of the exon 3 deletion of GH receptor and IGF-I l..:

Andujar-Plata, P. ; Fernandez-Rodriguez, E. ; Quinteiro, C...
Pituitary.  18 (2014)  1 - p. 101-107 , 2014
Link: https://doi.org/10.1007/..
 
?
7

Epidemiology, mortality rate and survival in a homogeneous ..:

Fernandez‐Rodriguez, E. ; Lopez‐Raton, M. ; Andujar, P....
Clinical Endocrinology.  78 (2013)  2 - p. 278-284 , 2013
Link: https://doi.org/10.1111/..
 
?
8

Pegvisomant and cabergoline combination therapy in acromega..:

Bernabeu, I. ; Alvarez-Escolá, C. ; Paniagua, A. E....
Pituitary.  16 (2012)  1 - p. 101-108 , 2012
Link: https://doi.org/10.1007/..
 
?
9

Somatotroph Tumor Progression during Pegvisomant Therapy: A..:

Marazuela, M. ; Paniagua, A. E. ; Gahete, M. D....
The Journal of Clinical Endocrinology & Metabolism.  96 (2011)  2 - p. E251-E259 , 2011
Link: https://doi.org/10.1210/..
 
?
10

Somatotroph Tumor Progression during Pegvisomant Therapy: A..:

Marazuela, M. ; Paniagua, A. E. ; Gahete, M. D....
Endocrine Reviews.  31 (2010)  6 - p. 946-946 , 2010
Link: https://doi.org/10.1210/..
 
?
11

Introducción:

Bernabeu, I. ; Páramo, C. ; Pico, A.
Endocrinología y Nutrición.  57 (2010)  - p. 1 , 2010
Link: https://doi.org/10.1016/..
 
?
12

Nell'acromegalia la delezione dell'esone 3 del recettore de..:

Bernabeu, I. ; Alvarez-Escolà, C. ; Quinteiro, C....
L'Endocrinologo.  11 (2010)  4 - p. 182-183 , 2010
Link: https://doi.org/10.1007/..
 
?
13

Somatotroph Tumor Progression during Pegvisomant Therapy: A..:

Bernabeu, I. ; Castaño, J. P. ; Fernandez-Rodriguez, E....
Endocrinology.  151 (2010)  12 - p. 5974-5974 , 2010
Link: https://doi.org/10.1210/..
 
?
14

Nell'acromegalia la delezione dell'esone 3 del recettore de..:

Bernabeu, I. ; Alvarez-Escolá, C. ; Quinteiro, C....
L'Endocrinologo.  11 (2010)  5 - p. 231-232 , 2010
Link: https://doi.org/10.1007/..
 
?
15

Características de la versión española del cuestionario de ..:

Bernabeu, I.J. ; Gaztambide, S. ; Menéndez, E....
Endocrinología y Nutrición.  49 (2002)  4 - p. 105-112 , 2002
Link: https://doi.org/10.1016/..
 
1-15